Enanta Pharmaceuticals (NASDAQ:ENTA) reported quarterly losses of $(1.27) per share which beat the analyst consensus estimate of $(1.35) by 5.93 percent. This is a 4.1 percent decrease over losses of $(1.22) per share from the same period last year. The company reported quarterly sales of $20.32 million which missed the analyst consensus estimate of $22.86 million by 11.12 percent. This is a 13.82 percent decrease over sales of $23.57 million the same period last year.
$100 Invested In Hormel Foods 15 Years Ago Would Be Worth This Much Today
Hormel Foods (NYSE:HRL) has outperformed the market over the past 15 years by 5.38% on an annualized basis producing an average annual return of 12.45%. Currently, Hormel Foods has a market capitalization of $27.08 billion.
